1
|
Rehman S, Barker S, Jose K, Callisaya M, Castley H, Schultz MG, Moore MN, Simpson DB, Peterson GM, Gall S. Co-Designed Cardiac Rehabilitation for the Secondary Prevention of Stroke (CARESS): A Pilot Program Evaluation. Healthcare (Basel) 2024; 12:776. [PMID: 38610198 PMCID: PMC11012137 DOI: 10.3390/healthcare12070776] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2024] [Revised: 03/22/2024] [Accepted: 03/28/2024] [Indexed: 04/14/2024] Open
Abstract
Structured health system-based programs, such as cardiac rehabilitation, may reduce the risk of recurrent stroke. This study aimed to co-design and evaluate a structured program of rehabilitation, developed based on insights from focus groups involving stroke survivors and health professionals. Conducted in Tasmania, Australia in 2019, the 7-week program comprised one hour of group exercise and one hour of education each week. Functional capacity (6 min walk test), fatigue, symptoms of depression (Patient Health Questionnaire), and lifestyle were assessed pre- and post-program, with a historical control group for comparison. Propensity score matching determined the average treatment effect (ATE) of the program. Key themes from the co-design focus groups included the need for coordinated care, improved psychosocial management, and including carers and peers in programs. Of the 23 people approached, 10 participants (70% men, mean age 67.4 ± 8.6 years) completed the program without adverse events. ATE analysis revealed improvements in functional capacity (139 m, 95% CI 44, 234) and fatigue (-5 units, 95% CI -9, -1), with a small improvement in symptoms of depression (-0.8 units, 95% CI -1.8, 0.2) compared to controls. The co-designed program demonstrated feasibility, acceptability, and positive outcomes, suggesting its potential to support stroke survivors.
Collapse
Affiliation(s)
- Sabah Rehman
- Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS 7000, Australia; (S.R.); (S.B.); (K.J.); (M.C.); (M.N.M.)
| | - Seamus Barker
- Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS 7000, Australia; (S.R.); (S.B.); (K.J.); (M.C.); (M.N.M.)
| | - Kim Jose
- Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS 7000, Australia; (S.R.); (S.B.); (K.J.); (M.C.); (M.N.M.)
| | - Michele Callisaya
- Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS 7000, Australia; (S.R.); (S.B.); (K.J.); (M.C.); (M.N.M.)
- Peninsula Clinical School, Monash University, Frankston, VIC 3199, Australia
| | - Helen Castley
- Royal Hobart Hospital, Tasmanian Health Service, Hobart, TAS 7000, Australia;
| | - Martin G. Schultz
- Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS 7000, Australia; (S.R.); (S.B.); (K.J.); (M.C.); (M.N.M.)
| | - Myles N. Moore
- Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS 7000, Australia; (S.R.); (S.B.); (K.J.); (M.C.); (M.N.M.)
| | - Dawn B. Simpson
- College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, NSW 2308, Australia;
| | - Gregory M. Peterson
- School of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7005, Australia
| | - Seana Gall
- Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS 7000, Australia; (S.R.); (S.B.); (K.J.); (M.C.); (M.N.M.)
- Faculty of Medicine, Dentistry and Health Sciences, Monash University, Melbourne, VIC 3800, Australia
| |
Collapse
|